This blog features original legal analysis written by attorneys at Whitman Mesothelioma Law Firm. Articles cover recent mesothelioma verdicts, asbestos regulation changes, trust fund developments, veterans benefits updates, and legal strategy for mesothelioma and asbestos cases. Each article is authored by a licensed attorney with decades of asbestos litigation experience.
Asbestos Trust Funds Hold Over $30 Billion — What It Means for Mesothelioma Victims in 2026
Analysis of trust fund filings shows more than $30 billion remains available across 60+ active asbestos bankruptcy trust funds. Most mesothelioma patients qualify for multiple trusts based on their exposure history.
Camp Lejeune Justice Act: What Veterans with Mesothelioma Need to Know
The Camp Lejeune Justice Act allows veterans and their families exposed to contaminated water at Camp Lejeune between 1953 and 1987 to file claims. Veterans with additional asbestos exposure may have separate mesothelioma claims.
Long-Term Data Confirms Immunotherapy Extends Mesothelioma Survival
Updated data from the CheckMate 743 clinical trial confirms sustained survival benefits for pleural mesothelioma patients treated with the nivolumab and ipilimumab immunotherapy combination — the first FDA-approved mesothelioma treatment in 16 years.
EPA Finalizes Comprehensive Ban on Chrysotile Asbestos: What It Means for Workers and Patients
In March 2024, the EPA finalized the first comprehensive federal ban on chrysotile asbestos in U.S. history. While a milestone, the ban does not require removal of legacy asbestos from existing buildings — and workers remain at risk.